| Microorganism | MIC50  (μg/ml)
 | MIC90  (μg/ml)
 | Range  (μg/ml)
 | Antimicrobial  | Reference | 
            
			        
			            | Escherichia coli (SHV-1 + penicillin-resistant) | - | - | 0.39 - ? | Imipenem  | 40 | 
                
			        
			            | Escherichia coli (SHV-1 + penicillin-resistant) | - | - | 0.39 - ? | Levofloxacin (Levaquin, Quixin)  | 40 | 
                
			        
			            | Escherichia coli (SHV-1 + penicillin-resistant) | - | - | 0.78 - ? | Faropenem  | 40 | 
                
			        
			            | Escherichia coli (SHV-1) | - | - | 2 - ? | Ceftazidime (Ceptaz, Fortaz, Tanicef)  | 187 | 
                
			        
			            | Escherichia coli (SHV-2) | - | - | 0.25 - ? | Ceftazidime (Ceptaz, Fortaz, Tanicef)  | 187 | 
                
			        
			            | Escherichia coli (SHV-3) | - | - | 0.125 - ? | Ceftazidime (Ceptaz, Fortaz, Tanicef)  | 187 | 
                
			        
			            | Escherichia coli (SHV-4) | - | - | >64 - ? | Ceftazidime (Ceptaz, Fortaz, Tanicef)  | 187 | 
                
			        
			            | Escherichia coli (SHV-5) | - | - | 16 - ? | Ceftazidime (Ceptaz, Fortaz, Tanicef)  | 187 | 
                
			        
			            | Escherichia coli (SHV-5) | - | - | 200 - ? | Ceftazidime (Ceptaz, Fortaz, Tanicef)  | 221 | 
                
			        
			            | Escherichia coli (SHV-producing) | 0.016 | 0.125 | <0.008 - 0.5 | Ertapenem (Invanz)  | 4 | 
                
			        
			            | Escherichia coli (SHV-producing) | 0.125 | 0.25 | 0.03 - 2 | Imipenem  | 4 | 
                
			        
			            | Escherichia coli (SHV-producing) | 0.5 | 8 | <0.125 - 32 | Tobramycin (Tobrex, Nebcin)  | 4 | 
                
			        
			            | Escherichia coli (SHV-producing) | 1 | 8 | <0.25 - 8 | Amikacin (Amikin)  | 4 | 
                
			        
			            | Escherichia coli (SHV-producing) | 2 | 16 | <0.25 - 64 | Zosyn  | 4 | 
                
			        
			            | Escherichia coli (SHV-producing) | 4 | 8 | 1 - 32 | Cefoxitin (Mefoxin)  | 4 | 
                
			        
			            | Escherichia coli (SHV-producing) | 8 | 16 | <0.125 - >128 | Levofloxacin (Levaquin, Quixin)  | 4 | 
                
			        
			            | Escherichia coli (SHV-producing) | 8 | 32 | 2 - 32 | Amoxicillin-clavulanate  | 4 | 
                
			        
			            | Escherichia coli (SHV-producing) | 16 | 64 | <0.125 - 128 | Ciprofloxacin (Cipro, Ciproxin, Ciprobay)  | 4 | 
                
			        
			            | Escherichia coli (SHV-producing) | 16 | 256 | 2 - >512 | Ceftriaxone (Rocephin)  | 4 | 
                
			        
			            | Escherichia coli (SHV-producing) | 32 | 128 | <0.25 - >256 | Ceftazidime (Ceptaz, Fortaz, Tanicef)  | 4 | 
                
			        
			            | Escherichia coli (SHY-1 + cefdinir-susceptible) | - | - | 0.12 - ? | Cefixime (Suprax)  | 267 | 
                
			        
			            | Escherichia coli (SHY-1 + cefdinir-susceptible) | - | - | 0.25 - ? | Cefdinir (Omnicef, Cefdiel)  | 267 | 
                
			        
			            | Escherichia coli (SM1411 + acr(AB)) | - | - | 4 - ? | Rifampicin (Rifampin)  | 1373 | 
                
			        
			            | Escherichia coli (SM1411 + acr(AB)) | - | - | >128 - ? | Corallopyronin A  | 1373 | 
                
			        
			            | Escherichia coli (SN -07 + O1:K1) | - | - | 20 - ? | Harmane  | 1290 | 
                
			        
			            | Escherichia coli (SN -07 + O1:K1) | - | - | 155 - ? | Harmaline  | 1290 | 
                
			        
			            | Escherichia coli (SN -07 + O1:K1) | - | - | 310 - ? | Harmine  | 1290 | 
                
			        
			            | Escherichia coli (SN -07 + O1:K1) | - | - | 380 - ? | Peganum harmala (Crude extract)  | 1290 |